Kalyani Vemuri

Lack of ST2 aggravates glioma invasiveness, vascular abnormality, and immune suppression

Wicher, Grzegorz; Roy, Ananya; Vaccaro, Alessandra; Vemuri, Kalyani et al.

Ingår i Neuro-Oncology Advances, 2025

• DOI för Lack of ST2 aggravates glioma invasiveness, vascular abnormality, and immune suppression
• Ladda ner fulltext (pdf) av Lack of ST2 aggravates glioma invasiveness, vascular abnormality, and immune suppression

CD93 maintains endothelial barrier function and limits metastatic dissemination

Vemuri, Kalyani; de Alves Pereira, Beatriz; Fuenzalida, Patricia; Subashi, Yelin et al.

Ingår i JCI Insight, 2024

• DOI för CD93 maintains endothelial barrier function and limits metastatic dissemination
• Ladda ner fulltext (pdf) av CD93 maintains endothelial barrier function and limits metastatic dissemination

AAV-mouse DNase I sustains long-term DNase I expression in vivo and suppresses breast cancer metastasis

Herre, Melanie; Vemuri, Kalyani; Cedervall, Jessica; Nissl, Stefanie et al.

Ingår i FASEB Bioadvances, s. 454-466, 2024

• DOI för AAV-mouse DNase I sustains long-term DNase I expression in vivo and suppresses breast cancer metastasis
• Ladda ner fulltext (pdf) av AAV-mouse DNase I sustains long-term DNase I expression in vivo and suppresses breast cancer metastasis

Preclinical Photodynamic Therapy Targeting Blood Vessels with AGuIX^® Theranostic Nanoparticles

Kowolik, Ewa; Szczygiel, Dariusz; Szczygiel, Malgorzata; Drzal, Agnieszka et al.

Ingår i Cancers, 2024

• DOI för Preclinical Photodynamic Therapy Targeting Blood Vessels with AGuIX^® Theranostic Nanoparticles
• Ladda ner fulltext (pdf) av Preclinical Photodynamic Therapy Targeting Blood Vessels with AGuIX^® Theranostic Nanoparticles

Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in glioma

Ramachandran, Mohanraj; Vaccaro, Alessandra; van de Walle, Tiarne; Georganaki, Maria et al.

Ingår i Cancer Cell, s. 1134-1151, 2023

• DOI för Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in glioma
• Ladda ner fulltext (pdf) av Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in glioma

Lack of ST2 aggravates glioma invasiveness, vascular abnormality, and immune suppression

Wicher, Grzegorz; Roy, Ananya; Vaccaro, Alessandra; Vemuri, Kalyani et al.

Ingår i Neuro-Oncology Advances, 2025

• DOI för Lack of ST2 aggravates glioma invasiveness, vascular abnormality, and immune suppression
• Ladda ner fulltext (pdf) av Lack of ST2 aggravates glioma invasiveness, vascular abnormality, and immune suppression

CD93 maintains endothelial barrier function and limits metastatic dissemination

Vemuri, Kalyani; de Alves Pereira, Beatriz; Fuenzalida, Patricia; Subashi, Yelin et al.

Ingår i JCI Insight, 2024

• DOI för CD93 maintains endothelial barrier function and limits metastatic dissemination
• Ladda ner fulltext (pdf) av CD93 maintains endothelial barrier function and limits metastatic dissemination

AAV-mouse DNase I sustains long-term DNase I expression in vivo and suppresses breast cancer metastasis

Herre, Melanie; Vemuri, Kalyani; Cedervall, Jessica; Nissl, Stefanie et al.

Ingår i FASEB Bioadvances, s. 454-466, 2024

• DOI för AAV-mouse DNase I sustains long-term DNase I expression in vivo and suppresses breast cancer metastasis
• Ladda ner fulltext (pdf) av AAV-mouse DNase I sustains long-term DNase I expression in vivo and suppresses breast cancer metastasis

Preclinical Photodynamic Therapy Targeting Blood Vessels with AGuIX^® Theranostic Nanoparticles

Kowolik, Ewa; Szczygiel, Dariusz; Szczygiel, Malgorzata; Drzal, Agnieszka et al.

Ingår i Cancers, 2024

• DOI för Preclinical Photodynamic Therapy Targeting Blood Vessels with AGuIX^® Theranostic Nanoparticles
• Ladda ner fulltext (pdf) av Preclinical Photodynamic Therapy Targeting Blood Vessels with AGuIX^® Theranostic Nanoparticles

Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in glioma

Ramachandran, Mohanraj; Vaccaro, Alessandra; van de Walle, Tiarne; Georganaki, Maria et al.

Ingår i Cancer Cell, s. 1134-1151, 2023

• DOI för Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in glioma
• Ladda ner fulltext (pdf) av Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in glioma

CD93 maintains endothelial barrier function by limiting the phosphorylation and turnover of VE-cadherin

Lugano, Roberta; Vemuri, Kalyani; Barbera, Stefano; Orlandini, Maurizio et al.

Ingår i The FASEB Journal, 2023

• DOI för CD93 maintains endothelial barrier function by limiting the phosphorylation and turnover of VE-cadherin
• Ladda ner fulltext (pdf) av CD93 maintains endothelial barrier function by limiting the phosphorylation and turnover of VE-cadherin

A method for Boolean analysis of protein interactions at a molecular level

Raykova, Doroteya; Kermpatsou, Despoina; Malmqvist, Tony; Harrison, Philip J et al.

Ingår i Nature Communications, 2022

• DOI för A method for Boolean analysis of protein interactions at a molecular level
• Ladda ner fulltext (pdf) av A method for Boolean analysis of protein interactions at a molecular level

ELTD1-deletion reduces vascular abnormality and improves T-cell recruitment after PD-1 blockade in glioma.

Huang, Hua; Georganaki, Maria; Conze, Lei Liu; Laviña, Bàrbara et al.

Ingår i Neuro-Oncology, s. 398-411, 2021

• DOI för ELTD1-deletion reduces vascular abnormality and improves T-cell recruitment after PD-1 blockade in glioma.
• Ladda ner fulltext (pdf) av ELTD1-deletion reduces vascular abnormality and improves T-cell recruitment after PD-1 blockade in glioma.

CD93 promotes β1 integrin activation and fibronectin fibrillogenesis during tumor angiogenesis

Lugano, Roberta; Vemuri, Kalyani; Yu, Di; Bergqvist, Michael et al.

Ingår i Journal of Clinical Investigation, s. 3280-3297, 2018

• DOI för CD93 promotes β1 integrin activation and fibronectin fibrillogenesis during tumor angiogenesis
• Ladda ner fulltext (pdf) av CD93 promotes β1 integrin activation and fibronectin fibrillogenesis during tumor angiogenesis

CD93 in regulation of vascular function and tumour progression

Vemuri, Kalyani

2022

• Ladda ner fulltext (pdf) av CD93 in regulation of vascular function and tumour progression

Global gene expression analysis of distant organ vasculature in mice with cancer

Herre, Melanie; Cedervall, Jessica; Vemuri, Kalyani; Lugano, Roberta et al.

CD93 stabilizes endothelial junctions and preserves blood-brain barrier integrity

Roberta, Lugano; Vemuri, Kalyani; Barbera, Stefano; Orlandini, Maurizio et al.

CD93 limits VEGFR2 activation and preserves endothelial barrier function in metastatic cancer

Vemuri, Kalyani; de Alves Pereira, Beatriz; Fuenzalida, Patricia; Subashi, Yelin et al.

Multispectral imaging identifies CD93 as a tumor endothelial marker associated with vascular proliferation and poor patient survival in glioblastoma

Vemuri, Kalyani; Klemm, Anna; Huang, Hua; Wik, Lina et al.